Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dexmedetomidine
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
3Dexmedetomidine 2
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
4Dexmedetomidine 3
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
5Dexmedetomidine group
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
6Dexmedetomidine Hcl 100 Mcg/mL Inj
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
7DEXMEDETOMIDINE HYDROCHLORIDE
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
8Dexmedetomidine Hydrochloride Infusion
(D00514)		1件: Dexmedetomidine1件: Dexmedetomidine (D00514) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
9Dexmedetomidine with ropivacaine
(D00514)		2件: Dexmedetomidine,
Ropivacaine		2件: Dexmedetomidine (D00514),
Ropivacaine 💬		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
10Fentanyl (Low Dose) + Dexmedetomidine
(D00514)		2件: Dexmedetomidine,
Fentanyl		2件: Fentanyl ,
Dexmedetomidine (D00514) 💬		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
11Scopolamine, atropine, edaravone and dexmedetomidine
(D00514)		4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		4件: Atropine ,
Scopolamine ,
Dexmedetomidine (D00514),
Edaravone 💬		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬